SCM-181

N/A

Report date: 2024/11/19 16:31:23

Base Information

Drug NameSCM-181

Drug Alias NamehPC-MSCSCM-181SCM181

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Placenta chorion-derived

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesYunnan Shunxi Regenerative Medicine Engineering Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesYunnan Shunxi Regenerative Medicine Engineering Co Ltd

Inactive CompaniesN/A

Active IndicationsIdiopathic Pulmonary Fibrosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A